ANNALS OF VASCULAR SURGERY, cilt.28, sa.2, ss.479-488, 2014 (SCI-Expanded)
Background: Cilostazol is a phosphodiesterase inhibitor that has anti-inflammatory potential in addition to vasodilator and antiplatelet effects. The aim of this study was to determine the influence of cilostazol on biochemical markers of oxidative damage, proinflammatory cytokine release, and spinal cord injury after transient aortic occlusion in rats.